Phase I trial of intranasal anthrax vaccine (AdVAV)
Not yet recruiting
Phase of Trial: Phase I
Latest Information Update: 28 Nov 2017
At a glance
- Drugs AdVAV (Primary)
- Indications Anthrax
- Focus Adverse reactions
- 22 Nov 2017 Status changed from planning to not yet recruiting.
- 05 May 2017 According to aN Altimmune media release, this study is expected to begin during 1Q18 with data anticipated 2Q18.
- 19 Jan 2017 According to a PharmAthene media release, this study is expected to begin during the second half of 2017 with data anticipated during the first half of 2018.